Date updated:08-04-2007
No description available

-
ACEL
- $0.00
- 0.00%
- $N/A
Onconase phase IIIb

-
ARNA
Arena Pharmaceuti - $3.51
- -0.85%
- $3.50
Obesity drug blockbuster potential

-
BIOM
N/a - $0.54
- 0.00
- $0.54
Stimuvax phase III trial Merck Serono partnership

-
DNDN
Dendreon Corporat - $28.01
- -0.14%
- $28.51
Hottest and most controversial cancer vaccine

-
ENMD
Entremed - $1.03
- -6.36%
- $1.07
Interesting pipeline

-
GERN
Geron Corporation - $5.58
- -2.62%
- $5.65
Must have speculation

-
GNBT
Generex Biotechno - $0.50
- -1.96%
- $0.508
Speculation

-
GNVC
Genvec - $0.8799
- +3.52%
- $0.8399
Must have speculation
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more
Here are some of the largest % gainers from Nov. 20, 2009. more
Analyst Upgrades or Estimate Increases for Nov. 20, 2009. Read more here. more













Comments not available